Qureight: Series BEnd-to-end imaging company for clinical trials with a focus on lung and heart disease.Oct 4, 2026RoundOSQureightCompany profile and funding historySourcesbusinesswire.comMore in HealthtechMetriport · Series AProFound Therapeutics · StrategicArintra · Series BAIUnited KingdomEnterprise softwareHealthtechEuropeSeries B